FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for fenofibrate filed by Cipla USA Inc. under the ANDA 208709.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia
• Mixed Dyslipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)